Unrivaled Brands, Inc.
USD0.01
-0.00 (-7.41%)
CEO
Sabas Carrillo
IPO Date
2012-05-10
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$3.60
Market Cap
$0.00B
Volume
0.76M
| -2.4 |
| 31 Dec 2020 | FY | 25.2% | -187.9% | -49.1% | -26.8% | 0.42 | 1.42 | -1.1 |
| 31 Dec 2019 | FY | 52.2% | -197.2% | -78.8% | -46.4% | 0.39 | 0.34 | -0.3 |
| 31 Dec 2018 | FY | 39.7% | -126.9% | -42.3% | -33.1% | 0.20 | 2.75 | -1.0 |
| 31 Dec 2017 | FY | 15.3% | -91.3% | -43.1% | -33.3% | 0.09 | 1.23 | -0.5 |
| 31 Dec 2016 | FY | 10.2% | -106.3% | -51.1% | -35.3% | 0.04 | 0.58 | -0.3 |
| 31 Dec 2015 | FY | 10.2% | -92.5% | -148.6% | -100.7% | 0.15 | 0.81 | -0.2 |
| 31 Dec 2014 | FY | 2.2% | -308.5% | -1395.7% | -283.6% | 2.94 | 0.31 | -0.1 |
| 31 Dec 2013 | FY | 4.2% | -289.2% | -7364.4% | -152.2% | 15.57 | 0.06 | -0.3 |
| -2.8 |
| 31 Mar 2023 | Q1 | 47.9% | 4.7% | -1.2% | 1.0% | -1.44 | 0.14 | 8.4 |
| 31 Dec 2022 | Q4 | 43.8% | 40.9% | -9.8% | 8.8% | -1.36 | 0.08 | 0.7 |
| 30 Sept 2022 | Q3 | -0.6% | -1114.8% | 284.9% | -222.8% | -1.15 | 0.10 | -0.0 |
| 30 Jun 2022 | Q2 | 47.1% | -374.0% | -85.0% | -36.4% | 0.65 | 0.24 | -0.2 |
| 31 Mar 2022 | Q1 | 31.0% | -51.3% | -7.6% | -4.3% | 0.40 | 0.31 | -2.4 |
| 31 Dec 2021 | Q4 | 38.2% | -75.7% | -6.8% | -3.6% | 0.56 | 0.29 | -2.6 |
| 30 Sept 2021 | Q3 | 9.8% | -22.8% | -4.0% | -2.1% | 0.23 | 1.04 | -5.8 |
| 30 Jun 2021 | Q2 | 37.3% | -65.6% | -7.4% | -3.8% | 0.40 | 1.26 | -4.4 |